Glutamine

Glial remodeling and neuroprotective effects of L-glutamine supplementation on the enteric nervous system in walker-256 tumor-bearing rats.

Cancer cachexia is characterized by systemic inflammation and severe metabolic imbalance, which may compromise the cellular components of the enteric nervous system (ENS). Oxidative stress associated with tumor growth can contribute to enteric neuropathy and gastrointestinal dysfunction. This study investigated...

🗓️ 2026-05-31
📰 Publication: Tissue & Cell
Read MoreGlial remodeling and neuroprotective effects of L-glutamine supplementation on the enteric nervous system in walker-256 tumor-bearing rats.

Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.

The neutral amino acid transporter SLC7A8 (LAT2) has been described as a key regulator of metabolic adaptation. LAT2 mutations in human populations have been linked to the early onset of age-related hearing loss and cataract growth. As LAT2 was previously...

🗓️ 2025-06-01
📰 Publication: Journal Of Cachexia Sarcopenia And Muscle
Read MoreAblation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis.

Haptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy.

Anticancer chemotherapy is an underappreciated contributor to cancer cachexia, an often-irreversible body-wasting condition that causes 20%-30% of cancer-related deaths. An obstacle to predicting, monitoring and understanding the mechanisms underlying chemotherapy cachexia is that each cancer (and subtype) is assigned different...

🗓️ 2025-06-01
📰 Publication: Journal Of Cachexia Sarcopenia And Muscle
Read MoreHaptoglobin and Glutamine Synthetase May Biomark Cachexia Induced by Antiacute Myeloid Leukaemia Chemotherapy.

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!